Bayer, Reckitt among final contenders for Merck consumer health care unit
Merck & Co. Inc. is in the final stages of selling its consumer health care unit for nearly $14 billion, with Bayer AG and Reckitt Benckiser Group Plc among final contenders to clinch a deal as soon as this week, people familiar with the matter said.
Germany's Bayer and British consumer products giant Reckitt have emerged as front-runners to win the auction after each offering about $13.5 billion for the Merck consumer unit, best known for Coppertone sunscreen and Claritin allergy medicine, the sources said.
Both bidders are very keen to buy the asset, and the price tag could go higher in the final days, one person added. All the people asked not to be named because the matter is not public.
Representatives of American drugmaker Merck, as well as Bayer and Reckitt, declined to comment.
Show commenting policy
TribLive commenting policy
- Blizzard-stricken East digs out amid forecast 2nd-guessing
- House passes bill aimed at expediting natural gas exports
- Pittsburgh travelers feel effects of Northeast blizzard
- Medicare payments to tie doctor, hospital payments to quality rather than volume of care
- New York father kils 3 generations of family, himself
- Ramping up e-cigarette voltage may be more hazardous to health
- Orcas could land on endangered list
- VA plans major structure changes; Pittsburgh’s fate as regional HQ remains unclear
- House sales tax proposal criticized as attack on states’ rights
- Wisconsin’s Walker takes first step toward possible run in 2016
- Marine Corps’ general outlines priorities, vision